Provided by Tiger Fintech (Singapore) Pte. Ltd.

Forte BioSciences Inc

11.32
+0.97009.37%
Post-market: 11.10-0.2200-1.94%19:58 EDT
Volume:19.01K
Turnover:205.66K
Market Cap:74.52M
PE:-1.37
High:11.32
Open:10.50
Low:10.35
Close:10.35
Loading ...

Forte Biosciences initiated with a Buy at Lucid Capital

TIPRANKS
·
05 Jun

Forte Biosciences Inc. Conducted Annual Stockholders Meeting

Reuters
·
30 May

Top Premarket Decliners

MT Newswires Live
·
19 May

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
19 May

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
16 May

TD Cowen Remains a Buy on Forte Biosciences (FBRX)

TIPRANKS
·
16 May

Forte Biosciences Inc reports results for the quarter ended March 31 - Earnings Summary

Reuters
·
16 May

BRIEF-Forte Biosciences Q1 Operating Expenses USD 16.124 Million

Reuters
·
16 May

Forte Biosciences Q1 EPS $(1.37) Misses $(0.96) Estimate

Benzinga
·
16 May

Forte Biosciences Reports Increased Q1 2025 Net Loss of $15.7M and EPS of $(1.37) Amid Higher R&D Expenses

Reuters
·
16 May

Forte Biosciences, Inc. Announces Results and Provides Update

THOMSON REUTERS
·
16 May

Forte Biosciences Inc expected to post a loss of 95 cents a share - Earnings Preview

Reuters
·
09 May

Investors Parse Earnings Reports as US Futures Dip in Fridays Premarket

MT Newswires Live
·
25 Apr

Chardan Adjusts Price Target on Forte Biosciences to $61 From $64, Maintains Buy Rating

MT Newswires Live
·
02 Apr

Forte Biosciences Is Maintained at Buy by Chardan Capital

Dow Jones
·
02 Apr

Forte Biosciences price target lowered to $61 from $64 at Chardan

TIPRANKS
·
02 Apr

Forte Biosciences (FBRX) Gets a Buy from TD Cowen

TIPRANKS
·
01 Apr

Forte Biosciences, Inc. Announces Results and Provides Clinical Update

THOMSON REUTERS
·
31 Mar

Press Release: Forte Biosciences, Inc. Announces Results and Provides Clinical Update

Dow Jones
·
31 Mar

Forte Biosciences Inc reports results for the quarter ended December 31 - Earnings Summary

Reuters
·
29 Mar